Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001140361-26-044530

Options or other derivatives

  • President/CEO acquired 19,255,711 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BEDU-ADDO FRANK · President/CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-16 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +2,698,978 $0.92 2036-11-16 2,698,978 2,698,978 D
2026-11-16 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +16,556,733 $0.92 2036-11-16 16,556,733 16,556,733 D
Loading xslF345X06/form4.xml…